| Literature DB >> 36045369 |
Yawei Wang1, Yan Wang2, Liaonan Zou3,4, Lingna Deng5, Tianchong Wu6, Linsen Liu6, Jiling Jiang7, Tailai An8.
Abstract
BACKGROUND: For sigmoid colon or rectal cancer, a definite consensus regarding the optimal level ligating the inferior mesenteric artery (IMA) has not been reached. We performed this study to determine whether the ligation level significantly affected short-term and long-term outcomes of patients with sigmoid colon or rectal cancer after curative laparoscopic surgery.Entities:
Keywords: Anastomotic fistula; High tie; Inferior mesenteric artery; Laparoscopic surgery; Low tie; Short-term and long-term outcomes
Mesh:
Year: 2022 PMID: 36045369 PMCID: PMC9434919 DOI: 10.1186/s12957-022-02741-9
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 3.253
Fig. 1Representative images demonstrating HT and LT. A During LT, IMA, and LCA was skeletonized and preserved, while superior rectal artery (SRA) and sigmoid artery (SA) were ligated. Additionally, apical lymph nodes were dissected. B During HT, IMA was ligated at its origin with dissecting apical lymph nodes
Comparisons between LT and HT regarding baseline characteristics
| Characteristics | Ligation level | |||
|---|---|---|---|---|
| Low ( | High ( | Value | value | |
| Age | 58.47 ± 12.82 | 57.53 ± 12.36 | 0.908 | 0.364 |
| ≤ 65 y | 209 (68.1%) | 201 (71.0%) | 0.603 | 0.437 |
| > 65 y | 98 (31.9%) | 82 (29.0%) | ||
| Gender | 2.976 | 0.085 | ||
| Male | 175 (57.0%) | 181 (64.0%) | ||
| Female | 132 (43.0%) | 102 (36.0%) | ||
| Diabetes and/or hypertension | 2.435 | 0.119 | ||
| Yes | 47 (15.3%) | 31 (11.0%) | ||
| No | 260 (86.7%) | 252 (89.0%) | ||
| Tumor size | 0.595 | 0.441 | ||
| ≤ 5 cm | 218 (71.0%) | 209 (73.9%) | ||
| > 5 cm | 89 (29.0%) | 74 (26.1%) | ||
| Location | 3.575 | 0.059 | ||
| Sigmoid colon | 109 (35.5%) | 122 (43.1%) | ||
| Rectum | 198 (64.5%) | 161 (56.9%) | ||
| Gross morphology | 0.632 | 0.729 | ||
| Mass forming | 97 (31.6%) | 95 (33.6%) | ||
| Ulcerative | 174 (56.7%) | 160 (56.5%) | ||
| Infiltrative | 36 (11.7%) | 28 (9.9%) | ||
| Differentiation | 2.430 | 0.297 | ||
| Well | 18 (5.9%) | 20 (7.1%) | ||
| Moderate | 257 (83.7%) | 223 (78.8%) | ||
| Poor | 32 (10.4%) | 40 (14.1%) | ||
| Histological component | 0.825 | 0.662 | ||
| Adenocarcinoma | 295 (96.1%) | 268 (94.7%) | ||
| Mucinous carcinoma | 11 (3.6%) | 13 (4.6%) | ||
| Signet-ring cell carcinoma | 1 (0.3%) | 2 (0.7%) | ||
| Vascular invasion | 0.992 | 0.319 | ||
| No | 295 (96.1%) | 267 (94.3%) | ||
| Yes | 12 (3.9%) | 16 (5.7%) | ||
| Nerve invasion | 0.184 | 0.668 | ||
| No | 301 (98.0%) | 276 (97.5%) | ||
| Yes | 6 (2.0%) | 7 (2.5%) | ||
| Depth of invasion | 6.306 | 0.098 | ||
| T1 | 12 (3.9%) | 7 (2.5%) | ||
| T2 | 72 (23.5%) | 46 (16.2%) | ||
| T3 | 141 (45.9%) | 149 (52.7%) | ||
| T4 | 82 (26.7%) | 81 (28.6%) | ||
| Lymph node metastasis | 2.450 | 0.294 | ||
| N0 | 189 (61.6%) | 159 (56.2%) | ||
| N1 | 71 (23.1%) | 81 (28.6%) | ||
| N2 | 47 (15.3%) | 43 (15.2%) | ||
| pTNM | 5.285 | 0.071 | ||
| I | 69 (22.5%) | 43 (15.2%) | ||
| II | 120 (39.1%) | 116 (41.0%) | ||
| III | 118 (38.4%) | 124 (43.8%) | ||
| CEA level (μg/L) | 0.653 | 0.419 | ||
| ≤ 5 | 205 (66.8%) | 180 (63.6%) | ||
| > 5 | 102 (33.2%) | 103 (36.4%) | ||
| Chemotherapy | 2.059 | 0.151 | ||
| No | 170 (55.4%) | 140 (49.5%) | ||
| Yes | 137 (44.6%) | 143 (50.5%) | ||
Comparisons between LT and HT in terms of short-term outcomes
| Characteristics | Low tie ( | High tie ( | ||
|---|---|---|---|---|
| Operation time | 214.46 ± 83.90 | 216.90 ± 78.71 | −0.365 | 0.715 |
| Blood transfusion | 3 (1.0%) | 2 (0.7%) | 0.000 | 1.000 |
| Estimated blood loss | 159.65 ± 29.65 | 157.11 ± 22.58 | 1.179 | 0.239 |
| 30-day mortality | 1 (0.3%) | 0 (0%) | 0.000 | 1.000 |
| ICU stay | 3 (1.0%) | 1 (0.4%) | 0.177 | 0.674 |
| Postoperative hospital stay (days) | 11.06 ± 1.84 | 11.29 ± 1.72 | −0.475 | 0.636 |
| Bowel obstruction | 5 (1.6%) | 6 (2.1%) | 0.194 | 0.659 |
| Ileus | 3 (1.0%) | 5 (1.8%) | 0.223 | 0.637 |
| Anastomotic fistula | 11 (3.6%) | 21 (7.4%) | 4.227 | 0.040 |
| Surgical site infection | 7 (2.3%) | 13 (4.6%) | 2.407 | 0.121 |
| Number of retrieved lymph nodes | 20.40 ± 8.32 | 20.89 ± 9.11 | −0.673 | 0.501 |
| Number of metastatic lymph nodes | 1.55 ± 3.29 | 2.09 ± 5.08 | −1.513 | 0.131 |
Anastomotic fistula
| Grade of leakage | Low tie ( | High tie ( |
|---|---|---|
| Grade 2 | 7 (2.3%) | 15 (5.3%) |
| Grade 3a | 0 (0%) | 0 (0%) |
| Grade 3b | 3 (1.0%) | 0 (0%) |
| Grade 4 | 0 (0%) | 5 (1.8%) |
| Grade 5 | 1 (0.3%) | 1 (0.4%) |
| Total | 11 (3.6%) | 21 (7.4%) |
Binary logistic regression performed to identify independent predictive factors for anastomotic fistula
| Characteristics | Anastomotic fistula | Binary logistic regression analysis | ||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | 95% CI for Exp(B) | ||||||
| ( | ( | Lower | Upper | |||||
| Gender | 4.473 | 0.034 | 0.425 | 0.180 | 1.005 | 0.051 | ||
| Male | 25 (78.1%) | 331 (59.3%) | ||||||
| Female | 7 (21.9%) | 227 (40.7%) | ||||||
| Age | 0.009 | 0.925 | ||||||
| ≤ 65 | 22 (78.1%) | 388 (69.5%) | ||||||
| > 65 | 10 (78.1%) | 170 (30.5%) | ||||||
| Diabetes and/or hypertension | 0.154 | 0.695 | ||||||
| Yes | 3 (9.4%) | 75 (13.4%) | ||||||
| No | 29 (90.6%) | 483 (86.6%) | ||||||
| Tumor size | 0.117 | 0.733 | ||||||
| ≤ 5 cm | 24 (75.0%) | 403 (72.2%) | ||||||
| > 5 cm | 8 (25.0%) | 155 (27.8%) | ||||||
| Location | 4.240 | 0.039 | 2.590 | 1.092 | 6.143 | 0.031 | ||
| Sigmoid colon | 7 (21.9%) | 224 (40.1%) | ||||||
| Rectum | 25 (78.1%) | 334 (59.9%) | ||||||
| Ligation level | 4.227 | 0.040 | 2.232 | 1.047 | 4.758 | 0.038 | ||
| LT | 11 (34.4%) | 296 (53.0%) | ||||||
| HT | 21 (65.6%) | 262 (47.0%) | ||||||
Urinary performance assessed by IPSS and ICIQ
| Characteristics | Low tie ( | High tie ( | ||
|---|---|---|---|---|
| ICIQ (preop) | 2.71 ± 0.693 | 3.00 ± 0.667 | −1.637 | 0.107 |
| ICIQ (1 month) | 3.61 ± 0.761 | 5.11 ± 0.685 | −7.896 | 0.000 |
| ICIQ (9 months) | 3.06 ± 0.727 | 5.86 ± 0.651 | −15.478 | 0.000 |
| IPSS (preop) | 14.19 ± 1.195 | 13.86 ± 1.113 | 1.115 | 0.269 |
| IPSS (1 month) | 18.16 ± 1.344 | 18.18 ± 1.335 | −0.049 | 0.961 |
| IPSS(9 months) | 16.16 ± 1.573 | 20.79 ± 1.449 | −11.704 | 0.000 |
Fig. 2Kaplan-Meier analyses performed to assess the impacts of ligation level on OS and RFS. A Ligation level did not significantly affect OS. B Ligation level did not significantly affect RFS
Fig. 3Kaplan-Meier analyses performed to assess the impacts of ligation level on OS and RFS of patients with cancer of different stages. A Ligation level did not significantly affect OS of patients with stage 1 cancer. B Ligation level did not significantly affect OS of patients with stage 2 cancer. C Ligation level did not significantly affect OS of patients with stage 3 cancer. D Ligation level did not significantly affect RFS of patients with stage 1 cancer. E Ligation level did not significantly affect RFS of patients with stage 2 cancer. F Ligation level did not significantly affect RFS of patients with stage 3 cancer
Cox proportional-hazard regression for OS
| Characteristics | Univariate analysis | Multivariate analysis | ||||||
|---|---|---|---|---|---|---|---|---|
| HR | 95% CI for Exp(B) | HR | 95% CI for Exp(B) | |||||
| Lower | Upper | Lower | Upper | |||||
| Gender | 0.659 | 1.071 | 0.791 | 1.449 | ||||
| Age | 0.007 | 1.527 | 1.125 | 2.074 | 0.000 | 2.011 | 1.464 | 2.763 |
| Tumor size | 0.265 | 0.819 | 0.577 | 1.163 | ||||
| Gross morphology | 0.813 | 1.029 | 0.811 | 1.307 | ||||
| Differentiation | 0.000 | 0.291 | 0.211 | 0.400 | 0.000 | 0.436 | 0.288 | 0.662 |
| Histological component | 0.000 | 2.291 | 1.483 | 3.539 | ||||
| T | 0.000 | 1.581 | 1.285 | 1.946 | ||||
| N | 0.000 | 2.059 | 1.718 | 2.469 | 0.007 | 1.577 | 1.133 | 2.196 |
| pTNM | 0.000 | 2.126 | 1.681 | 2.688 | 0.038 | 1.609 | 1.344 | 2.079 |
| Vascular invasion | 0.000 | 4.157 | 2.603 | 6.638 | 0.029 | 1.832 | 1.063 | 3.159 |
| Nerve invasion | 0.002 | 3.063 | 1.506 | 6.233 | ||||
| CEA | 0.008 | 1.505 | 1.112 | 2.035 | ||||
| Ligation level | 0.475 | 1.115 | 0.827 | 1.503 | ||||
Cox proportional-hazard regression for RFS
| Characteristics | Univariate analysis | Multivariate analysis | ||||||
|---|---|---|---|---|---|---|---|---|
| HR | 95% CI for Exp(B) | HR | 95% CI for Exp(B) | |||||
| Lower | Upper | Lower | Upper | |||||
| Gender | 0.891 | 1.021 | 0.759 | 1.373 | ||||
| Age | 0.174 | 1.237 | 0.910 | 1.680 | ||||
| Tumor size | 0.109 | 0.753 | 0.532 | 1.066 | ||||
| Gross morphology | 0.810 | 1.029 | 0.815 | 1.299 | ||||
| Differentiation | 0.000 | 0.317 | 0.232 | 0.433 | 0.002 | 0.548 | 0.374 | 0.802 |
| Histological component | 0.008 | 1.849 | 1.178 | 2.901 | ||||
| T | 0.000 | 1.680 | 1.371 | 2.060 | ||||
| N | 0.000 | 2.343 | 1.965 | 2.793 | 0.003 | 1.598 | 1.168 | 2.186 |
| pTNM | 0.000 | 2.690 | 2.102 | 3.443 | 0.028 | 1.897 | 1.248 | 2.257 |
| Vascular invasion | 0.000 | 4.328 | 2.764 | 6.779 | ||||
| Nerve invasion | 0.000 | 4.146 | 2.251 | 7.636 | 0.047 | 1.946 | 1.010 | 3.751 |
| CEA | 0.034 | 1.378 | 1.025 | 1.852 | ||||
| Ligation level | 0.722 | 1.054 | 0.788 | 1.410 | ||||